Standard Operating Procedure for Sterility Testing of Injectable Products
| Department | Sterile Injectable Manufacturing |
|---|---|
| SOP No. | SOP/SIM/061/2025 |
| Supersedes | SOP/SIM/061/2022 |
| Page No. | Page 1 of 15 |
| Issue Date | 18/06/2025 |
| Effective Date | 20/06/2025 |
| Review Date | 18/06/2026 |
1. Purpose
This SOP outlines the method for conducting sterility testing of injectable products to detect the presence of viable microorganisms in sterile pharmaceutical preparations using validated test procedures as per pharmacopoeial standards.
2. Scope
This SOP is applicable to all final sterile injectable
drug products manufactured in-house and intended for release after sterility testing at [Company Name] microbiology laboratory.
3. Responsibilities
- Microbiology Analyst: Performs sterility testing following aseptic techniques and documents the observations.
- Quality Control Manager: Reviews and approves sterility test records and results.
- Quality Assurance: Ensures compliance with regulatory requirements and reviews final reports.
4. Accountability
Head – Quality Control shall be accountable for execution and compliance of the sterility testing process.
5. Procedure
5.1 Pre-Test Preparations
- Verify cleanliness and calibration status of the sterility test isolator or laminar air flow workbench.
- Check environmental monitoring results prior to test initiation.
- Ensure media (FTM and SCDM) are clear, not expired, and pass growth promotion tests.
- Label test containers with sample code and media type.
5.2 Sampling and Media
- Use Fluid Thioglycollate Medium (FTM) for anaerobic and aerobic bacteria.
- Use Soybean Casein Digest Medium (SCDM) for fungi and aerobic bacteria.
- Samples shall be tested within 24 hours of sampling. If delayed, store at 2–8°C (not exceeding 72 hours).
5.3 Sterility Test Methods
5.3.1 Membrane Filtration Method (Preferred)
- Assemble sterile filtration apparatus and membrane units inside isolator/LAF under Grade A conditions.
- Filter product through 0.45 µm or finer filter.
- Rinse filters with sterile fluid (minimum three rinses of 100 mL).
- Transfer one filter to FTM and another to SCDM.
- Incubate FTM at 30–35°C and SCDM at 20–25°C for 14 days.
5.3.2 Direct Inoculation Method (If Filtration Not Feasible)
- Inoculate a measured quantity of the product directly into FTM and SCDM media.
- Observe for signs of turbidity or microbial growth over 14 days.
5.4 Controls and Monitoring
- Include negative controls with media only (no product) in every run.
- Perform growth promotion test on positive control organisms (B. subtilis, C. albicans, etc.) periodically.
- Document incubator temperature, media lot, test environment, and analyst details.
5.5 Observation and Results
- Visually inspect test media daily for turbidity or sediment formation.
- Record observations in the Sterility Test Log (Annexure-1).
- If microbial growth is observed, isolate, identify the organism, and initiate an OOS investigation.
6. Abbreviations
- SOP: Standard Operating Procedure
- FTM: Fluid Thioglycollate Medium
- SCDM: Soybean Casein Digest Medium
- OOS: Out of Specification
- LAF: Laminar Air Flow
7. Documents
- Sterility Test Log – Annexure-1
- Growth Promotion Test Records – Annexure-2
- Sterility Test Report Format – Annexure-3
8. References
- USP <71> Sterility Tests
- EP 2.6.1 Sterility
- WHO TRS 1010, Annex 6
9. SOP Version
Version: 2.0
10. Approval Section
| Prepared By | Checked By | Approved By | |
|---|---|---|---|
| Signature | |||
| Date | |||
| Name | |||
| Designation | QC Analyst | QC Manager | Head QA |
| Department | Quality Control | Quality Control | Quality Assurance |
11. Annexures
Annexure-1: Sterility Test Log
| Date | Batch No. | Product Name | Media Used | Observation | Analyst |
|---|---|---|---|---|---|
| 17/06/2025 | IVINJ0234 | Inj. Ceftriaxone | FTM/SCDM | No Growth | Neha Verma |
Annexure-2: Growth Promotion Test Record
| Media | Organism | Inoculum | Result | Date | Analyst |
|---|---|---|---|---|---|
| FTM | B. subtilis | 100 CFU | Growth | 16/06/2025 | Sagar Patil |
Annexure-3: Sterility Test Report
| Product | Batch | Test Date | Result | Reviewed By |
|---|---|---|---|---|
| Inj. Pantoprazole | IVPNT045 | 15/06/2025 | Complies | Dr. Sheetal Nair |
Revision History
| Revision Date | Revision No. | Details | Reason | Approved By |
|---|---|---|---|---|
| 01/01/2022 | 1.0 | Initial release | New SOP | QA Head |
| 18/06/2025 | 2.0 | Updated with detailed filtration and inoculation steps | Annual Review | QA Head |